Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher ClinicalTrials.gov — Target/Actual Enrollment by Year
Danaher ClinicalTrials.gov — Target/Actual Enrollment: 8,271 in FY2025, up 14.6% from a year earlier.
Latest, FY2025
8,271
Period ended Dec 31, 2025
Change on a year earlier
+14.6%
7,215 in FY2024
History
10 years
Since FY2016
Sources
1
NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry)
Where the FY2025 figure comes from
Source: NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗
Reported in NIH ClinicalTrials.gov API v2.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | ClinicalTrials.gov — Target/Actual Enrollment | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,271 | +14.6% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2024 | Dec 31, 2024 | 7,215 | +62.1% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2023 | Dec 31, 2023 | 4,452 | +9.9% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2022 | Dec 31, 2022 | 4,052 | -90.2% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2021 | Dec 31, 2021 | 41,204 | +2,701.1% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2020 | Dec 31, 2020 | 1,471 | -96.5% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2019 | Dec 31, 2019 | 42,367 | +1,512.1% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2018 | Dec 31, 2018 | 2,628 | -39.4% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2017 | Dec 31, 2017 | 4,335 | -18.5% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2016 | Dec 31, 2016 | 5,320 | – | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
Cite this data
StockData. (2026). Danaher ClinicalTrials.gov — Target/Actual Enrollment, annual FY2016–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-ct-enrollment-dhr-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.